FY2025 · period end Dec '25 · from the 10-K filed Feb 26, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Gross Profit | $59.91B | $64.61B | $61.46B | $55.68B | $56.52B |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B |
| Net Income | $5.96B | $3.43B | $5.16B | — | — |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B |
| Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B |
| Stockholders' Equity | $41.87B | $41.24B | $46.24B | $44.69B | $46.98B |
| Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B |
| Total Debt | $30.87B | $28.94B | $28.16B | $28.10B | $31.13B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 21.8% | 26.1% | 31.5% | 30.8% | 32.5% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.2% | 0.2% |
| Return on Equity | 14.3% | 7.9% | 11.4% | 88.0% | 85.3% |
| Return on Assets | 3.8% | 2.2% | 3.5% | 27.0% | 26.7% |
| Debt / Equity | 0.74× | 0.70× | 0.61× | 0.63× | 0.66× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001140361-26-020906 | May 13, 2026 | May 13, 2026 | May 13, 2026 10:01 UTC | EDGAR |
| 8-K | 0001140361-26-017971 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 10:15 UTC | EDGAR |
| 10-Q | 0001739940-26-000043 | Mar 31, 2026 | Apr 30, 2026 | Apr 30, 2026 15:47 UTC | EDGAR |
| 8-K | 0001140361-26-017123 | Apr 22, 2026 | Apr 27, 2026 | Apr 27, 2026 20:26 UTC | EDGAR |
| 8-K | 0001140361-26-007450 | Feb 25, 2026 | Mar 3, 2026 | Mar 3, 2026 12:42 UTC | EDGAR |
| 8-K | 0001140361-26-007049 | Feb 27, 2026 | Feb 27, 2026 | Feb 27, 2026 11:15 UTC | EDGAR |
| 10-K | 0001739940-26-000006 | Dec 31, 2025 | Feb 26, 2026 | Feb 26, 2026 17:08 UTC | EDGAR |
| 8-K | 0001140361-26-003768 | Feb 5, 2026 | Feb 5, 2026 | Feb 5, 2026 11:15 UTC | EDGAR |
Direct links to SEC EDGAR. CI has additional filings available on the SEC site.
6 numbers Cigna Group later changed — same XBRL tag, both filings linked.
Net Income (Loss) Available to Common Stockholders, Basic·Q1 2022
Minor restatementwas$1.2B
Revised up in a 10-Q.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q1 2022
Minor restatementwas$1.5B
Revised up in a 10-Q.
Operating Income (Loss)·Q1 2022
Minor restatementwas$2.2B
Revised up in a 10-Q.
Net Income (Loss) Available to Common Stockholders, Basic·FY 2022
Minor restatementwas$6.7B
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2022
Minor restatementwas$8.4B
Revised up in a 10-K.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent·Q1 2022
Major restatementwas$575M
Revised up in a 10-Q.
CI is not the only one.
See every restatement we've found across the market — or get an alert the next time CI revises a number.
Restatements are detected by comparing every vintage of a fact across all of Cigna Group's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CI's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Cigna Group — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CI yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CI and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs